Corning Incorporated (NYSE:GLW) stock price target increased to $30.00, released a research note earlier today by Zacks Investment Research
- Updated: April 21, 2017
Boasting a price of $27.11, Corning Incorporated (NYSE:GLW) traded 0.93% higher on the day. With the last close up 7.11% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. Corning Incorporated has recorded a 50-day average of $27.21 and a two hundred day average of $25.31. Volume of trade was up over the average, with 7,306,203 shares of GLW changing hands over the typical 6,748,200
Zacks Investment Research bumped up the target of Corning Incorporated (NYSE:GLW) to $30.00 stating a potential upside of 0.11%.
On Thursday April 20, 2017, Stifel Nicolaus released a statement on Corning Incorporated (NYSE:GLW) bumped up the target price from $0.00 to $28.00 that suggested an upside of 0.03%.
With a total market value of $0, Corning Incorporated has 52 week low of $18.21 and a 52 week high of $28.36 with a P/E ratio of 8.39 .
In addition to Zacks Investment Research reporting its target price, a total of 14 firms have reported on the stock. The consensus target price is $20.71 with 3 firms rating the stock a strong buy, 4 firms rating the stock a buy, 9 firms rating the stock a hold, 1 firm rating the stock a underperform, and finally 1 firm rating the stock a sell.
About Corning Incorporated (NYSE:GLW)
Corning Incorporated is engaged in manufacturing specialty glass and ceramics. Its segments include Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, Life Sciences and All Other. The Display Technologies segment manufactures glass substrates for flat panel liquid crystal displays (LCDs). The Optical Communications segment manufactures carrier and enterprise network components for the telecommunications industry. The Environmental Technologies segment manufactures ceramic substrates and filters for automotive and diesel emission control applications. As of December 31, 2016, the Specialty Materials segment manufactured products, which provided more than 150 material formulations for glass, glass ceramics and fluoride crystals. The Life Sciences segment manufactures glass and plastic labware, equipment, media and reagents. The All Other segment consists of its Pharmaceutical Technologies business and non-LCD glass business, and among others.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.